Ultime notizie per Lightning eMotors (OTC:ZEVY) Azioni

Lightning eMotors

Lightning eMotors Inc is engaged in designing and manufacturing zero-emission commercial trucks and buses and charging infrastructure solutions for fleets, large enterprises, original equipment manufacturers, and governments. Its product offerings range from cargo vans, transit and shuttle buses, school buses, specialty work trucks, ambulances, and electric powertrains for school buses, transit buses, and motor coaches. Its product solutions help its customers reduce their greenhouse gas emissions, lower operating costs and improve energy efficiency.

LIGHTNING EMOTORS INC by Lightning eMotors, Inc.

Lightning eMotors Inc

Lightning eMotors Inc Warrants (18/05/2025)

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reportedly has over 10,000 units of the Cybertruck in its domestic inventory as the company grapples with poor sales and an aging line-up of vehicles.
What Happened: Elon Musk's EV giant could be sitting on over $800 million worth of Cybertruck inventory, according <a href="https://electrek.co/2025/05/05/tesla-cybertruck-inventory-skyrockets-to-record-high/">to</a> an Electrek report on Monday.
The report suggests that despite there not being a way to track Tesla units in the U.S., listings of Tesla models can be tracked. The report also outlines how Tesla may publish a single listing for multiple vehicles at the same location with the same features, which could indicate the company has more inventory.
Tesla did not immediately respond to<a href="http://pro.benzinga.com"> Benzinga's</a> request for comment.
Why It Matters: Tesla has been grappling with declining sales figures in the U.S. as well as Europe. The company's market share in Europe currently stands at 2%, down from 2.9% last year, and it registered 571 units sold in Spain, according to experts.
Cybertruck also went through a <a href="https://www.benzinga.com/news/25/04/44967503/cybertruck-gets-a-down-to-earth-redesign-as-tesla-shifts-to-traditional-pickup-marketing-amid-poor-s">shift in marketing strategy</a>, which positions the vehicle as a capable, rugged pickup truck and expands on its utilitarian quotient. The company also released a <a href="https://www.benzinga.com/markets/equities/25/04/44755221/tesla-unveils-new-cybertruck-long-range-trim-with-a-362-mile-range-and-reduced-features">cheaper, RWD variant </a>of the Cybertruck to appeal to a wider customer base.
Tesla's new <a href="https://www.benzinga.com/tech/25/04/44857987/tesla-experiences-151-decline-in-new-vehicle-registrations-in-california-report">vehicle registrations </a>also fell in California, and the company's profits declined by over 71% YoY. This comes at a time when the company was reportedly exploring <a href="https://www.benzinga.com/25/04/45124373/tesla-board-explored-replacing-elon-musk-as-tesla-ceo-a-month-ago-report">a future without Musk</a>, which both the billionaire as well as the company have categorically denied.
Price Action: TSLA currently trades for $280.26 on the NASDAQ, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45214525/gary-black-flags-47-projected-drop-in-teslas-april-europe-sales-predicts-6-decline-in-2025-deliveries">Gary Black Flags 47% Projected Drop In Tesla&#8217;s April Europe Sales, Predicts 6% Decline In 2025 Deliveries</a></li>
</ul>
Photo courtesy: Shutterstock

News

Markets

Tech

General

TSLA

Tesla Has Over 10,000 Units Of Unsold Cybertrucks In Its US Inventory Amid Poor Sales: Report

Guidance

PINC

Premier Raises FY25 Adj EPS Guidance From $1.26 - $1.34 To $1.37 - $1.43 Vs. $1.29 Est.

SEAT

Due To Uncertainty Across The Global Economy, Vivid Seats Is Suspending Guidance For The Year Ending December 31, 2025

AG Mortgage Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.17 by 23.53 percent. This is unchanged from the same period last year.

Earnings

Earnings Beats

MITT

AG Mortgage Investment Q1 Adj. EPS $0.21 Beats $0.17 Estimate

IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $(0.67) by 22.39 percent. This is a 54.72 percent decrease over losses of $(0.53) per share from the same period last year.

Earnings Misses

IDYA

IDEAYA Biosciences Q1 EPS $(0.82) Misses $(0.67) Estimate

Premier Updates FY25 Net Revenue Excluding Contigo Health Outlook From $940B - $1.01B to $955M - $995M

Buybacks

CLDT

Chatham Lodging Trust Board Approves First-Ever $25M Share Buyback Program With No Time Limit

Chardan Capital analyst Geulah Livshits maintains Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) with a Buy and maintains $13 price target.

Price Target

Analyst Ratings

IMRX

Chardan Capital Maintains Buy on Immuneering, Maintains $13 Price Target

2025 Financial Outlook Given the uncertainty in industry production caused by the evolving tariff environment, we are not reaffirming&nbsp;our 2025 financial outlook at this time. We remain confident in delivering the operating performance commitments for 2025 that we highlighted in our February 2025 earnings call. We intend to provide updates as visibility on industry production improves.

Lear Not Reaffirming 2025 Financial Outlook Given The Uncertainty In Industry Production Caused By Evolving Tariff Environment

Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) affirms FY2025 Adj EPS guidance from $1.91-$1.98 to $1.91-$1.98 vs $1.91 analyst estimate..

ARMK

Aramark Affirms FY2025 Adj EPS Guidance of $1.91-$1.98 vs $1.91 Est

Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.30 by 46.67 percent. This is a 20 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $261.38 million which beat the analyst consensus estimate of $240.45 million by 8.71 percent. This is a 23.71 percent decrease over sales of $342.60 million the same period last year.

Premier Q3 Adj. EPS $0.44 Beats $0.30 Estimate, Sales $261.38M Beat $240.45M Estimate

Chatham Lodging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDT#NYSE">CLDT</a>) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 12.5 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $68.64 million which beat the analyst consensus estimate of $68.34 million by 0.43 percent. This is a 0.28 percent increase over sales of $68.44 million the same period last year.

Chatham Lodging Q1 FFO $0.14, Inline, Sales $68.64M Beat $68.34M Estimate

Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) reported quarterly sales of $164.02 million which missed the analyst consensus estimate of $169.71 million by 3.35 percent. This is a 14.06 percent decrease over sales of $190.85 million the same period last year.

Vivid Seats Q1 Sales $164.02M Miss $169.71M Estimate

Omnicell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) is looking for Q2 Adj EPS of $0.19-$0.32 vs $0.42 analyst estimate. sees sales of $270.000 million-$280.000 million vs $278.32 million analyst estimate.

OMCL

Omnicell Sees Q2 Adj EPS $0.19-$0.32 vs $0.42 Est; Sees Sales $270.000M-$280.000M vs $278.32M Est

Omnicell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) lowers FY2025 Adj EPS guidance from $1.65-$1.85 to $1.00-$1.65 vs $1.77 analyst estimate. Affirms FY2025 sales outlook from $1.10 billion-$1.16 billion to $1.10 billion-$1.16 billion vs $1.13 billion estimate.

Omnicell Lowers FY2025 Adj EPS Guidance from $1.65-$1.85 to $1.00-$1.65 vs $1.77 Est; Affirms FY2025 Sales Guidance of $1.10B-$1.16B vs $1.13B Est

Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) reported quarterly earnings of $3.12 per share which beat the analyst consensus estimate of $2.70 by 15.56 percent. This is a 1.89 percent decrease over earnings of $3.18 per share from the same period last year. The company reported quarterly sales of $5.56 billion which beat the analyst consensus estimate of $5.52 billion by 0.64 percent. This is a 7.26 percent decrease over sales of $6.00 billion the same period last year.

Lear Q1 Adj. EPS $3.12 Beats $2.70 Estimate, Sales $5.56B Beat $5.52B Estimate

Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.33 by 3.03 percent. This is a 17.24 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $4.28 billion which missed the analyst consensus estimate of $4.35 billion by 1.72 percent. This is a 1.88 percent increase over sales of $4.20 billion the same period last year.

Aramark Q2 Adj. EPS $0.34 Beats $0.33 Estimate, Sales $4.28B Miss $4.35B Estimate

Omnicell Q1 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $269.67M Beat $260.00M Estimate

Enpro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPO#NYSE">NPO</a>) affirms FY2025 Adj EPS guidance from $7.00-$7.70 to $7.00-$7.70 vs $7.34 analyst estimate..

Enpro Affirms FY2025 Adj EPS Guidance of $7.00-$7.70 vs $7.34 Est

Enpro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPO#NYSE">NPO</a>) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.67 by 13.77 percent. This is a 21.02 percent increase over earnings of $1.57 per share from the same period last year. The company reported quarterly sales of $273.20 million which beat the analyst consensus estimate of $266.23 million by 2.62 percent. This is a 6.10 percent increase over sales of $257.50 million the same period last year.

Comments

Lightning eMotors

Notizie

Ultime notizie per Lightning eMotors (OTC:ZEVY) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO